Compare BridgeBio Pharma Inc (BBIO) vs Msci Inc (MSCI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs Msci Inc — how do they compare? BridgeBio Pharma Inc trades at $83.9 (market cap $16.36B), while Msci Inc trades at $562 (market cap $40.84B). The key difference: Msci Inc is far larger — about 2.5× BridgeBio Pharma Inc's market cap, and Msci Inc pays a 1.46% dividend while BridgeBio Pharma Inc pays none. Which is the better fit depends on your goals.
| BBIO | MSCI | |
|---|---|---|
Market Cap | $16.36B | $40.84B |
Sector | Health | Financials |
52-Week High | $90.17 | $643.83 |
52-Week Low | $47.29 | $511.84 |
Enterprise Value | $18.14B | $47.00B |
Dividend Yield | — | 1.46% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About Msci Inc
MSCI describes its mission as enabling investors to build better portfolios for a better world. MSCI's largest and most profitable segment is its index segment, where it provides benchmarking to asset managers and asset owners. In addition, it boasts over $1 trillion in ETF assets linked to MSCI indexes. The MSCI analytics segment provides portfolio management and risk management analytics software to asset managers and asset owners. MSCI's all other segment was broken out into ESG and climate and private assets segments in 2021. In ESG and climate, MSCI provides ESG data to the investment industry. In the private assets side, MSCI provides real restate reporting, market data, benchmarking, and analytics to investors and real estate managers.
Read more on MSCI →
